A faster or slower metabolism can change how quickly your body processes the medication
At Genova Diagnostics, our testing is designed to look beneath the number on the scale and into the systems that determine how well a patient will actually live on GLP1 therapy: Gut health and the microbiome: Stool profiles (including GI Effects and targeted assays such as Akkermansia assessment) help clinicians understand digestion, inflammation, dysbiosis, and key organisms linked with metabolic health and GLP1 signaling
It involves growing bacteria such as Propionibacterium freudenreichii under controlled environment
Weight loss medications are evaluated on a case-by-case basis during the health screening
WUMO Peptide support is limited to B2B sourcing communication, documentation review, vial specification discussion, packaging coordination, and quotation preparation
It's unknown if combining them could exacerbate certain side effects